33.56
-0.22 (-0.65%)
| Penutupan Terdahulu | 33.78 |
| Buka | 33.91 |
| Jumlah Dagangan | 132,772 |
| Purata Dagangan (3B) | 538,826 |
| Modal Pasaran | 1,088,477,696 |
| Harga / Pendapatan (P/E TTM) | 16.29 |
| Harga / Pendapatan (P/E Ke hadapan) | 4.48 |
| Harga / Jualan (P/S) | 1.73 |
| Harga / Buku (P/B) | 3.45 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Aug 2026 |
| Margin Keuntungan | 6.61% |
| Margin Operasi (TTM) | 13.71% |
| EPS Cair (TTM) | 1.22 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 22.70% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -91.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 411.94% |
| Nisbah Semasa (MRQ) | 1.08 |
| Aliran Tunai Operasi (OCF TTM) | 198.44 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 341.32 M |
| Pulangan Atas Aset (ROA TTM) | 7.95% |
| Pulangan Atas Ekuiti (ROE TTM) | 19.23% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Menaik |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Menaik | |
| Stok | Collegium Pharmaceutical, Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.5 |
| Purata | 0.38 |
|
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 1.69% |
| % Dimiliki oleh Institusi | 117.12% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |